The funding came from investors within the spine industry and the Genesis Innovation Group, according to a Nov. 8 news release. Happe Spine plans to use the money to launch an implant for spinal fusions.
Happe Spine has a proprietary material platform, HydroxyApatite Porous Peek, for implants. The material’s allograft-like qualities are designed to help improve clinical outcomes in interbody spinal fusions.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
